Gregory T. Lucier

Chief Executive Officer

Greg Lucier founded Corza Health in partnership with leading private equity firm GTCR to combine his 30+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities.

Greg most recently served as Chairman and CEO at NuVasive, a global technology leader in minimally invasive spine and orthopedic surgery. Prior to that, he was Chairman and CEO at Life Technologies—formerly Invitrogen—which he grew into a global life sciences powerhouse that was acquired by Thermo Fisher Scientific for more than $15 billion. He spent the first part of his career with the General Electric—including GE Healthcare—in a variety of corporate officer and executive roles.

Greg serves on several public and private company boards, including Antylia Scientific, Catalent, Dentsply Sirona, Maravai LifeSciences, and Pleno, Inc. He has been actively involved in a variety of community and civic engagements, including serving as the Chairperson for Sanford Burnham Research Institute in La Jolla, California and the Smithsonian Natural History Museum.

He holds a Bachelor’s in Industrial Engineering from Pennsylvania State University and a Master’s in Business Administration from Harvard Business School.

In his free time, Greg enjoys riding motorcycles—both on and off-road—as well as skiing. His family are proud supporters of the Lucier Fund for Engineering Equity at Penn State.

Dennis Crowley

Executive Vice President, Corporate Development

Dennis Crowley brings nearly thirty years of experience in strategy and business development, driving organic and acquired growth through mergers and acquisitions, joint ventures, and strategic affiliations.

Dennis most recently served as SVP, Business Development & Licensing at Baxter Healthcare, a leader in treating kidney disease and other chronic and acute medical conditions. Dennis has also held executive leadership roles at Tyco International and Medtronic/Covidien, among others. He holds a Bachelor’s degree from Harvard College.

Brian Berning

Managing Director

Brian Berning brings 20+ years of strategic leadership to Corza Health, where he leverages his expertise in M&A, finance, operations, investor relations, corporate governance, risk management, and compliance to partner with management teams to accelerate growth and create significant value.

Brian most recently served as the CFO at GreatCall, the leading provider of connected health solutions for seniors. He successfully guided the company through its acquisition by GTCR in 2017 and ultimate sale to Best Buy a year later for $800 million.

Previously, as CFO at Human Longevity, a genomics and cellular therapy company, Berning helped the founders raise over $300 million and establish global operations.

Berning also served as SVP of Finance at LPL Financial, where he was the executive sponsor to the board for all operating efficiency initiatives and helped guide the company to a successful IPO. Brian began his career with Ernst & Young, LLP where he earned his CPA.

Brian holds a Bachelor’s in Business Administration from San Diego State University and a Master’s in Accounting from the University of Southern California.

As a San Diego native, Brian grew up surfing just a few steps from Corza Health’s headquarters. He continues to enjoy the outdoors and other adrenaline-inducing adventures to this day.